Newsfeeds Archive - Spark Newswire

2 minute read

Biote Announces Definitive Settlement With Founder, Company To Repurchase All Of Founder’s 18.4M Shares At $4.17 Per Share

April 29, 4:20 PM

Company to repurchase all of Founder's 18.4 million shares at $4.17 per sharebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of

BTMD

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

March 29, 4:30 PM

Gainers Qilian Intl Hldg Gr (NASDAQ:QLI) shares rose 63.8% to $1.04 during Friday’s after-market session. The market value…

APLT

2 minute read

Biote Announces Agreement To Resolve Litigation And Repurchase All Of Founder’s Shares; Company To Repurchase ~18.4M Class A Shares And Paired Interests At $4.17 Per Share

By Benzinga Newsdesk

February 20, 5:14 PM

Company to repurchase approximately 18.4 million Class A shares and Paired Interests at $4.17 per sharebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through

BTMD

1 minute read

Biote Announces $20M Share Repurchase Authorization

By Benzinga Newsdesk

January 25, 5:35 PM

biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that its

BTMD

2 minute read

Biote Announces Definitive Agreement To Acquire F.H. Investments, Inc., d/b/a Asteria Health, A Privately Held 503B Manufacturer Of Compounded Bioidentical Hormones For $8.5M

By Benzinga Newsdesk

January 17, 5:09 PM

Strategic and accretive transaction enables vertical integration of hormone product manufacturingbiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the

BTMD

2 minute read